These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9099970)

  • 1. Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families.
    Zelada-Hedman M; Børresen-Dale AL; Claro A; Chen J; Skoog L; Lindblom A
    Br J Cancer; 1997; 75(8):1201-4. PubMed ID: 9099970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening.
    Andersen TI; Eiken HG; Couch F; Kaada G; Skrede M; Johnsen H; Aloysius TA; Tveit KM; Tranebjaerg L; Dørum A; Møller P; Weber BL; Børresen-Dale AL
    Hum Mutat; 1998; 11(2):166-74. PubMed ID: 9482581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of the TP53 gene as a potential prognostic marker in breast carcinomas. Advantages of using constant denaturant gel electrophoresis in mutation detection.
    Andersen TI; Børresen AL
    Diagn Mol Pathol; 1995 Sep; 4(3):203-11. PubMed ID: 7493140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma.
    McIntyre JF; Smith-Sorensen B; Friend SH; Kassell J; Borresen AL; Yan YX; Russo C; Sato J; Barbier N; Miser J
    J Clin Oncol; 1994 May; 12(5):925-30. PubMed ID: 8164043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.
    Børresen AL; Hovig E; Smith-Sørensen B; Malkin D; Lystad S; Andersen TI; Nesland JM; Isselbacher KJ; Friend SH
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8405-9. PubMed ID: 1924299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis.
    Thorlacius S; Thorgilsson B; Björnsson J; Tryggvadottir L; Börresen AL; Ogmundsdottir HM; Eyfjörd JE
    Eur J Cancer; 1995 Oct; 31A(11):1856-61. PubMed ID: 8541113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material.
    Gretarsdottir S; Tryggvadottir L; Jonasson JG; Sigurdsson H; Olafsdottir K; Agnarsson BA; Ogmundsdottir H; Eyfjörd JE
    Br J Cancer; 1996 Aug; 74(4):555-61. PubMed ID: 8761369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for TP53 mutations in osteosarcomas using constant denaturant gel electrophoresis (CDGE).
    Smith-Sørensen B; Gebhardt MC; Kloen P; McIntyre J; Aguilar F; Cerutti P; Børresen AL
    Hum Mutat; 1993; 2(4):274-85. PubMed ID: 8401536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three germline mutations in the TP53 gene.
    Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ
    Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation screening of the TP53 gene by temporal temperature gradient gel electrophoresis.
    Sørlie T; Johnsen H; Vu P; Lind GE; Lothe R; Børresen-Dale AL
    Methods Mol Biol; 2005; 291():207-16. PubMed ID: 15502225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent TP53 missense mutation in cancer patients of Arab descent.
    Zick A; Kadouri L; Cohen S; Frohlinger M; Hamburger T; Zvi N; Plaser M; Avital E; Breuier S; Elian F; Salah A; Goldberg Y; Peretz T
    Fam Cancer; 2017 Apr; 16(2):295-301. PubMed ID: 27866339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of germline mutations of exons 5 to 8 of the P53 gene in 26 breast cancer families from the north of France.
    Preudhomme C; Fenaux P; Peyrat JP; Fournier J; Bonneterre J; Vennin P
    Eur J Cancer; 1993; 29A(10):1476-8. PubMed ID: 8398277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations.
    Phillips KA; Nichol K; Ozcelik H; Knight J; Done SJ; Goodwin PJ; Andrulis IL
    J Natl Cancer Inst; 1999 Mar; 91(5):469-73. PubMed ID: 10070948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
    Walsh T; Casadei S; Coats KH; Swisher E; Stray SM; Higgins J; Roach KC; Mandell J; Lee MK; Ciernikova S; Foretova L; Soucek P; King MC
    JAMA; 2006 Mar; 295(12):1379-88. PubMed ID: 16551709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for germline mutations of the p53 gene in familial breast cancer patients.
    Patel UA; Perry M; Crane-Robinson C
    Eur J Clin Invest; 1995 Feb; 25(2):132-7. PubMed ID: 7737263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
    Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
    Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer.
    Aceto GM; Solano AR; Neuman MI; Veschi S; Morgano A; Malatesta S; Chacon RD; Pupareli C; Lombardi M; Battista P; Marchetti A; Mariani-Costantini R; Podestà EJ
    Breast Cancer Res Treat; 2010 Aug; 122(3):671-83. PubMed ID: 19851859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline TP53 mutations in breast cancer families with multiple primary cancers: is TP53 a modifier of BRCA1?
    Martin AM; Kanetsky PA; Amirimani B; Colligon TA; Athanasiadis G; Shih HA; Gerrero MR; Calzone K; Rebbeck TR; Weber BL
    J Med Genet; 2003 Apr; 40(4):e34. PubMed ID: 12676907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.